Onabotulinum Toxin A (BoNT-A; Botox) Therapy Improves Drooling Severity in Children with Silorrhea and adverse effects were few, transient, and not severe.
Onabotulinum Toxin A (BoNT-A; Botox) Therapy Improves Drooling Severity in Children with Silorrhea and adverse effects were few, transient, and not severe.